Market Cap
$37.8M
SCLX
Scilex Holding Co
$4.06 ▼ -7.94%
Prev close $4.41Market cap$37.8M
Insider Buying Cluster (2 insiders)High Impact Filing (7/10)5 New Institutional Positions3 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on SCLX right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
36 funds
Inst. Value
$5.1M
Inst. Activity
5 buys / 3 sells
Insider Activity
$599.8K buy / $100.0K sell
Insider Net $
$499.9K
SEC Reports
7
Press Releases
4
Price chart 30d -23.1%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 11, 2026 earnings_calendar
Jul 22, 2026 SEC SCLX Q2 2026 Earnings Scheduled — 2026-08-11
Scilex Holding Co. completed the sale of its Vivasor preferred shares back to Vivasor for ~$12M, payable in five tranche
8-K — Impact 5/10
Scilex Holding Company announced a binding term sheet for a proposed $100M strategic investment from Kazakhstan-based iH
8-K — Impact 6/10
Jul 3, 2026 Insider
SCLX Stock Acquisition JV LLC disposed of 500,000 shares
10%+ Owner
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
33,376 shares ($260.3K)
Jun 30, 2026 Inst.
Jun 29, 2026 SEC MORGAN STANLEY — TRIM
4,032 shares ($31.5K)
Scilex Holding Co. entered a binding term sheet to purchase 837 Bitcoin from Datavault AI Inc. for $50 million, payable
8-K — Impact 7/10
Scilex Holding Company confirmed the payment date of June 15, 2026 for its previously announced dividend of Semnur Pharm
Impact 2/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Apr 11, 2025 | D. Boral Capital | DOWNGRADE | Hold | 33% |
| Apr 2, 2025 | D. Boral Capital | MAINTAIN | Buy | 33% |
| Feb 28, 2025 | D. Boral Capital | MAINTAIN | Buy | 33% |
| Jan 27, 2025 | D. Boral Capital | INITIATE | Buy | 33% |
| Oct 21, 2024 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Oct 16, 2024 | Alliance Global Partners | INITIATE | Buy | 42% |
| Jun 17, 2024 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Jun 13, 2024 | Rodman & Renshaw | INITIATE | Buy | 39% |
| Jun 11, 2024 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| May 23, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Aug 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jul 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jun 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% |
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 0 bullish, 3 bearish, 3 mixed, 1 neutral · avg impact 5.7/10.Plus 4 press releases.
MIXED8-K5/10
Scilex Holding Co. completed the sale of its Vivasor preferred shares back to Vivasor for ~$12M, pay
Jul 22, 2026
MIXED8-K6/10
Scilex Holding Company announced a binding term sheet for a proposed $100M strategic investment from
Jul 6, 2026
BEARISH8-K7/10
Scilex Holding Co. entered a binding term sheet to purchase 837 Bitcoin from Datavault AI Inc. for $
Jun 29, 2026
BEARISHEFFECT6/10
Scilex Holding Co's S-3 shelf registration (File No. 333-296430) became effective on June 11, 2026.
Jun 12, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 11, 2026
earnings_calendar
SCLX Q2 2026 Earnings Scheduled — 2026-08-11
Jul 17, 2026
Clinical Trial
Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
Phase Phase 2 — COMPLETED
Jul 6, 2026
other
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generati
Jun 16, 2026
other
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026
PALO ALTO, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generati
Jun 12, 2026
activist
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
PALO ALTO, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-gen
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own SCLX (from quarterly 13F filings) and who is adding or trimming.
36 institutional holders with $5.1M total value (678,392 shares) as of 2026-Q2. Top holders: VANGUARD, BlackRock,, VANGUARD. Net buying activity: 5 institutions added/increased vs 3 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 301,292 | $2.4M | 45.8% | — |
| BlackRock, Inc. | 109,417 | $853.5K | 16.6% | TRIM -25.7% |
| VANGUARD FIDUCIARY TRUST CO | 45,822 | $357.4K | 7.0% | — |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 41,163 | $321.1K | 6.3% | — |
| STATE STREET CORP | 35,376 | $275.9K | 5.4% | DOUBLED +181.2% |
| UBS Group AG | 33,376 | $260.3K | 5.1% | DOUBLED +416.0% |
| RENAISSANCE TECHNOLOGIES LLC | 33,064 | $257.9K | 5.0% | DOUBLED +100.7% |
| CITADEL ADVISORS LLC | 27,497 | $214.5K | 4.2% | — |
| NORTHERN TRUST CORP | 15,047 | $117.4K | 2.3% | — |
| MORGAN STANLEY | 4,032 | $31.5K | 0.6% | TRIM -66.3% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| UBS Group AG | DOUBLED | 6,468 | 33,376 | +416.0% | $260.3K |
| MORGAN STANLEY | TRIM | 11,973 | 4,032 | -66.3% | $31.5K |
| OSAIC HOLDINGS, INC. | DOUBLED | 98 | 2,339 | +2286.7% | $18.2K |
| JONES FINANCIAL COMPANIES LLLP | DOUBLED | 752 | 1,755 | +133.4% | $12.5K |
| US BANCORP \DE\ | ADD | 8 | 11 | +37.5% | $86.00 |
| Farther Finance Advisors, LLC | ADD | 4 | 7 | +75.0% | $55.00 |
| Allworth Financial LP | TRIM | 6 | 2 | -66.7% | $16.00 |
| FMR LLC | NEAR_EXIT | 12 | 1 | -91.7% | $8.00 |
| UBS Group AG | TRIM | 11,805 | 6,468 | -45.2% | $43.1K |
| OSAIC HOLDINGS, INC. | NEAR_EXIT | 1,148 | 98 | -91.5% | $639.00 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
3 insiders, 4 transactions. Net $499.9K — $599.8K bought, $100.0K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 3, 2026 | SCLX Stock Acquisition JV LLC | 10%+ Owner | J | 500,000 | — | — |
| Apr 17, 2026 | Ji Henry | Exec Chair, CEO and President | SELL | 650,000 | $0.1538 | $100.0K |
| Apr 17, 2026 | Ma Stephen Hoi | CFO, COO and Secretary | BUY | 650,000 | $0.1538 | $100.0K |
| Apr 16, 2026 | Ji Henry | Exec Chair, CEO and President | BUY | 3,250,000 | $0.1538 | $499.9K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SCLX.
Shares short
176,711
Settlement Sep 15, 2026
Change vs prior
+11.2%
Semi-monthly cycle
Days to cover
5.9
At avg daily volume
Of shares outstanding
≈2.1%
Estimate — not % of float
All SCLX filing & press-release reports (11)
- 8-K reportJul 22, 2026
- 8-K reportJul 6, 2026
- 8-K reportJun 29, 2026
- PRESS-RELEASE reportJun 12, 2026
- EFFECT reportJun 12, 2026
- INST-CLUSTER reportJun 11, 2026
- PRESS-RELEASE reportJun 4, 2026
- PRESS-RELEASE reportMay 5, 2026
- PRESS-RELEASE reportMay 4, 2026
- CLUSTER reportApr 20, 2026
- 8-K reportMar 13, 2026